home > research channels > sectors > pharma


Latest News
24-May-2018 Truncated Fortis Board Likely to Consider all Bids Submitted Earlier
23-May-2018 Aurobindo Restarts Talks to Buy Mallinckrodt¿s Opioid Business
21-May-2018 Ranbaxy Whistleblower Petitions PMO to Probe ¿Illegal¿ Drug Approvals
18-May-2018 Opioid-based Drug Crisis in US Gives Indian Pharma Players Hallucinations
  more...
Latest Reports
May-18 Trump scheduled speech on Pharma... - Emkay Research  
May-18 Strong deal flow in Emerging Market generics - IIFL  
Apr-18 Higher volumes continue supporting IPM growth - Motilal Oswal  
Apr-18 Mylan - a case study for Indian pharma - Edelweiss Securities  
  more...

Quarterly Summary March-2018
Desc Current Previous Per.Chg
Sales 16984.2 15796.6 7.5
Otherincome 1281.3 419.5 205.4
Expense 14119.6 13655.6 3.4
RawMaterial 5067.8 4240.1 19.5
StaffCost 2694.9 2374.4 13.5
ExciseDuty -0.1 107.4 -100.1
OtherExp 4643.2 5182.3 -10.4
Interest 203.5 206.4 -1.4
GrossProfit 4281.2 2698.8 58.6
Depreciation 797.6 794.1 0.4
Tax 770.5 191.2 303.0
NetProfit 2659.6 1723.3 54.3
Total.Comp 45 -- --
Source: ETIG Database

Sectoral Companies As on 25 May 2018
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 111939.34
Piramal Entp 43443.33
Cipla 43141.28
Biocon 39573.00
Cadila Healt 39156.53
Aurobindo Ph 34802.46
Lupin 33771.87
Dr.Reddy's 32717.76
Divi's Lab 30412.61
Alkem Labora 23319.42
Torrent Phar 22331.12
GlaxoSmith.P 19910.85
Glenmark Pha 15099.11
  click here for the complete list